Literature DB >> 6104132

Immunological conditioning of bone marrow for autotransplantation in childhood acute lymphoblastic leukaemia.

B Netzel, R J Haas, H Rodt, H J Kolb, S Thierfelder.   

Abstract

Samples of bone marrow from 32 leukaemic children were removed during remission and stored in liquid nitrogen for retransplantation during relapse. Subsequently two children in advanced stages of common acute lymphoblastic leukaemia (cALL) were transplanted with their own cryopreserved marrow cells, after intensive combination chemotherapy and high doses of radiation therapy. Before grafting, the marrow cells were treated with purified heterologous antibodies prepared against cALL antigens, to remove any residual tumour cells. The antibodies showed high cytotoxic activity against leukaemic cells of cALL type without interfering with normal haemopoietic stem cells. Evidence of take was obtained in one patient, who died on day 7 with cardiac failure. In the other patient the dose of nucleated marrow cells grafted was 1.9 x 10(8)/kg (86 000 CFU-C/kg). The patient achieved complete haematological recovery on day 27 and a normal platelet count after day 50 and is now in complete remission. Marrow cells collected during remission and treated with antileukaemic antibodies can repopulate bone marrow after conditioning of the recipient with high doses of radiation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6104132     DOI: 10.1016/s0140-6736(80)91787-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  6 in total

Review 1.  Progress in bone marrow transplantation in man.

Authors:  R P Gale
Journal:  Surv Immunol Res       Date:  1982

2.  Haemopoietic stem cell autografts for leukaemia.

Authors:  J M Goldman
Journal:  Blut       Date:  1980-08

3.  Clinical applications of monoclonal antibodies.

Authors:  K D Maudgil; S K Gupta; B S Narang
Journal:  Indian J Pediatr       Date:  1984 Nov-Dec       Impact factor: 1.967

4.  Current management of childhood acute lymphocytic leukemia.

Authors:  H Ekert
Journal:  Indian J Pediatr       Date:  1981 Jul-Aug       Impact factor: 1.967

5.  Recent advances in the treatment of acute lymphoblastic leukemia in adults and future prospects.

Authors:  B Clarkson; J Gaynor; B R Franza; M Furth
Journal:  Trans Am Clin Climatol Assoc       Date:  1985

Review 6.  Enzyme and membrane markers in leukaemia: recent developments.

Authors:  A V Hoffbrand; G Janossy
Journal:  J Clin Pathol       Date:  1981-03       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.